DE59813296D1 - Production of Human Mutant Proteins in Human Cells by Homologous Recombination - Google Patents

Production of Human Mutant Proteins in Human Cells by Homologous Recombination

Info

Publication number
DE59813296D1
DE59813296D1 DE59813296T DE59813296T DE59813296D1 DE 59813296 D1 DE59813296 D1 DE 59813296D1 DE 59813296 T DE59813296 T DE 59813296T DE 59813296 T DE59813296 T DE 59813296T DE 59813296 D1 DE59813296 D1 DE 59813296D1
Authority
DE
Germany
Prior art keywords
human
production
homologous recombination
mutant proteins
human cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE59813296T
Other languages
German (de)
Inventor
Anne Stern
Konrad Honold
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Roche Diagnostics GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8227102&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE59813296(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Roche Diagnostics GmbH filed Critical Roche Diagnostics GmbH
Application granted granted Critical
Publication of DE59813296D1 publication Critical patent/DE59813296D1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Mycology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE59813296T 1997-07-23 1998-07-22 Production of Human Mutant Proteins in Human Cells by Homologous Recombination Expired - Lifetime DE59813296D1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97112639 1997-07-23
PCT/EP1998/004583 WO1999005264A2 (en) 1997-07-23 1998-07-22 Production of human mutant proteins in human cells by homologous recombination

Publications (1)

Publication Number Publication Date
DE59813296D1 true DE59813296D1 (en) 2006-01-26

Family

ID=8227102

Family Applications (1)

Application Number Title Priority Date Filing Date
DE59813296T Expired - Lifetime DE59813296D1 (en) 1997-07-23 1998-07-22 Production of Human Mutant Proteins in Human Cells by Homologous Recombination

Country Status (17)

Country Link
US (2) US6444441B1 (en)
EP (1) EP1000167B2 (en)
JP (1) JP2001511341A (en)
KR (1) KR100512018B1 (en)
CN (2) CN101348789B (en)
AR (2) AR013251A1 (en)
AT (1) ATE313643T1 (en)
AU (1) AU729489B2 (en)
BR (1) BR9811531A (en)
CA (1) CA2297660C (en)
DE (1) DE59813296D1 (en)
DK (1) DK1000167T4 (en)
ES (1) ES2255177T5 (en)
PT (1) PT1000167E (en)
TR (1) TR200000172T2 (en)
WO (1) WO1999005264A2 (en)
ZA (1) ZA986517B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11320422B2 (en) * 2016-01-06 2022-05-03 Lonza Ltd. Inhibition of protein degradation for improved production

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234686A (en) * 1985-04-03 1993-08-10 Beecham Group P.L.C. Human tissue plasminogen activator consisting essentially of t-PA residues to 160 to 527, pharmaceutical compositions and methods of treatment
US5094953A (en) * 1988-03-21 1992-03-10 Genentech, Inc. Human tissue plasminogen activator variants
DE3903581A1 (en) 1989-02-07 1990-08-16 Boehringer Mannheim Gmbh FABRIC PLASMINOGEN ACTIVATOR DERIVATIVE
DE3907679A1 (en) * 1989-03-09 1990-09-13 Max Planck Gesellschaft METHOD FOR TARGETED CHANGING A GENE
JPH0576361A (en) * 1990-05-10 1993-03-30 Takeda Chem Ind Ltd Tissue plasminogen activator mutein
WO1992003917A1 (en) * 1990-08-29 1992-03-19 Genpharm International Homologous recombination in mammalian cells
AU664847B2 (en) * 1991-05-15 1995-12-07 Cell Genesys, Inc. Genomic modifications with homologous DNA targeting
US5641670A (en) * 1991-11-05 1997-06-24 Transkaryotic Therapies, Inc. Protein production and protein delivery
US6270989B1 (en) * 1991-11-05 2001-08-07 Transkaryotic Therapies, Inc. Protein production and delivery
WO1993022443A1 (en) * 1992-04-24 1993-11-11 Sri International In vivo homologous sequence targeting in eukaryotic cells
EP0656747A4 (en) * 1992-08-21 1997-05-07 Univ California Composition and method for altering dna sequences by homologous recombination.
TW402639B (en) * 1992-12-03 2000-08-21 Transkaryotic Therapies Inc Protein production and protein delivery
CN1256986C (en) * 1993-12-02 2006-05-24 转移染色体治疗公司 Production and transferring of protein
WO1996040271A1 (en) * 1995-06-07 1996-12-19 Yale University Treatment of hemoglobinopathies
US6087129A (en) * 1996-01-19 2000-07-11 Betagene, Inc. Recombinant expression of proteins from secretory cell lines

Also Published As

Publication number Publication date
AR068104A2 (en) 2009-11-04
AU9067398A (en) 1999-02-16
TR200000172T2 (en) 2000-12-21
US20020177195A1 (en) 2002-11-28
BR9811531A (en) 2000-08-22
PT1000167E (en) 2006-05-31
US6444441B1 (en) 2002-09-03
EP1000167B2 (en) 2011-04-20
KR100512018B1 (en) 2005-09-02
KR20010022127A (en) 2001-03-15
CA2297660A1 (en) 1999-02-04
DK1000167T4 (en) 2011-08-08
WO1999005264A2 (en) 1999-02-04
AU729489B2 (en) 2001-02-01
ATE313643T1 (en) 2006-01-15
ES2255177T5 (en) 2011-07-12
CA2297660C (en) 2010-04-27
AR013251A1 (en) 2000-12-13
US20020068318A1 (en) 2002-06-06
JP2001511341A (en) 2001-08-14
ZA986517B (en) 2000-01-24
CN101348789B (en) 2016-08-17
WO1999005264A3 (en) 1999-04-22
DK1000167T3 (en) 2006-04-24
EP1000167B1 (en) 2005-12-21
CN1265152A (en) 2000-08-30
ES2255177T3 (en) 2006-06-16
CN101348789A (en) 2009-01-21
EP1000167A2 (en) 2000-05-17

Similar Documents

Publication Publication Date Title
EE9700018A (en) Controlling the growth of cells encapsulated in biological artificial organs
DE60024988D1 (en) PREPARATION OF THERAPEUTIC MICROSCIENTS
ATE347911T1 (en) COMPOSITIONS FOR DELIVERY OF GENES TO ANTIGEN-PRESENTING CELLS OF THE SKIN
DE60038200D1 (en) production and use
AU2002356861A1 (en) Fibrin membrane and methods for its preparation- application to artificial skin
AU2002316230A1 (en) Methods of culturing animal cells and polypeptide production in animal cells
ATE326536T1 (en) PRODUCTION OF BIOLOGICALLY ACTIVE MOLECULES
DE69901177T2 (en) PLATINUM COMPLEX, THEIR PRODUCTION AND THEIR THERAPEUTIC USE
DE69824576D1 (en) USE OF TETRAHYDROPYRIDINE DERIVATIVES FOR THE MANUFACTURE OF MEDICAMENTS FOR THE TREATMENT OF DEMYELINISING DISEASES
NO20000097D0 (en) Isolated dendritic cell membrane protein genes
ATE514771T1 (en) HAIR TRANSPLANTATION
NO20006113L (en) Use of cyclosporins in the treatment of inflammatory autoimmune diseases
AU2002223593A1 (en) Regulation of human sphingosine kinase-like protein
AU2002335104A1 (en) Induction of beta cell differentiation in human cells
DE59813296D1 (en) Production of Human Mutant Proteins in Human Cells by Homologous Recombination
DE60028816D1 (en) Production of unipolar components
PT928197E (en) USE OF PROTEINS AS AGENTS AGAINST DISEASES OF AUTOIMUNITY NATURE
AU2002309989A1 (en) Directed evolution of protein in mammalian cells
ATE286127T1 (en) ADMINISTRATION OF THE THERAPEUTIC PROTEINS BY IMPLANTATION OF THE GENETICALLY MODIFIED CELLS INTO THE OMENTUM
NO20010044L (en) Use of texaphyrins in macrophage-mediated diseases
DE60037181D1 (en) PROCESS FOR THE PREPARATION OF POLYPEPTIDES IN CYCLOHEXADEPSIPEPTIDE DEFICIENT CELLS
NO20010355L (en) New peptides for use in immunotherapy of autoimmune diseases
ATE296352T1 (en) MATERIALS AND METHODS FOR MODULATING P66 EXPRESSION
FR2777906B1 (en) PRODUCTION OF HUMAN DENDRITIC CELLS DERIVED FROM MONOCYTES
AU2001274148A1 (en) Production of recombinant allergens in plant cells

Legal Events

Date Code Title Description
8363 Opposition against the patent